Defining treatment‐resistant depression

Gaynes, Bradley N., Lux, Linda, Gartlehner, Gerald, Asher, Gary, Forman‐Hoffman, Valerie, Green, Josh, Boland, Erin, Weber, Rachel P. +5 more·2020·Depression and Anxiety

DOI 10.1002/da.22968

Cited by (446)

Items 101–200 of 446

Early labor force exits in patients with treatment-resistant depression: an assessment of work years lost in a Danish nationwide register-based cohort study
Kathrine Bang Madsen, Liselotte Vogdrup Petersen, Oleguer Plana‐Ripoll, Katherine Louise Musliner, Jean-Christophe Debost, Frederikke Hørdam Gronemann, Preben Bo Mortensen, Trine Munk‐Olsen · 2020 · Therapeutic Advances in Psychopharmacology
Intensive rTMS for treatment-resistant depression patients with suicidal ideation: An open-label study.
Qi Wang, Hongfei Huang, Dongdong Li, Yi-Tong Wang, Na Qi, Yihong Ci, Tian-Chao Xu · 2022 · Asian Journal of Psychiatry
Prognostic Significance of Blood-Based Baseline Biomarkers in Treatment-Resistant Depression: A Literature Review of Available Studies on Treatment Response
Theano Gkesoglou, Stavroula I. Bargiota, Eleni Iordanidou, Miltiadis Vasiliadis, Vasilios‐Panteleimon Bozikas, Agorastos Agorastos · 2022 · Brain Sciences
Assessment of Objective and Subjective Cognitive Function in Patients With Treatment-Resistant Depression Undergoing Repeated Ketamine Infusions
Jennifer Lynne Phillips, Amanda Van Geel, Patricia Burhunduli, Dominique Vasudev, Lisa A. Batten, Sandhaya Norris, Jeanne D. Talbot, Abigail Ortiz, Olabisi Owoeye, Pierre Blier · 2022 · The International Journal of Neuropsychopharmacology
Sex Differences of the Functional Brain Activity in Treatment-Resistant Depression: A Resting-State Functional Magnetic Resonance Study
Ji-Fei Sun, Yi Luo, Yue Ma, Chun-Lei Guo, Z. Du, Shan-Shan Gao, Li-Mei Chen, Zhi Wang, Xiaojiao Li, Ke Xu et al. · 2022 · Brain Science
Changes in Adipokine, Resitin, and BDNF Concentrations in Treatment-Resistant Depression after Electroconvulsive Therapy
Agnieszka Permoda-Pachuta, Magda Malewska-Kasprzak, Maria Skibińska, Krzysztof Rzepski, Monika Dmitrzak‐Węglarz · 2023 · Brain Sciences
Clinical MRI morphological analysis of functional seizures compared to seizure-naïve and psychiatric controls
Wesley T. Kerr, Hiroyuki Tatekawa, John K. Lee, Amir H. Karimi, Siddhika S. Sreenivasan, Joseph O’Neill, Jena M. Smith, L. Brian Hickman, Ivanka Savic, Nilab Nasrullah et al. · 2022 · Epilepsy & Behavior
The co-occurrence of depression and dissociation: The relevance of childhood trauma
Hong Wang Fung, Grace W. K. Ho, Stanley Kam Ki Lam, Anson Kai Chun Chau, Vedat Şar, Colin A. Ross, Kun‐Hua Lee, Wai Tong Chien, Janet Yuen Ha Wong · 2025 · Journal of Psychiatric Research
Transcutaneous auricular vagus nerve immediate stimulation treatment for treatment-resistant depression: A functional magnetic resonance imaging study
Yue Ma, Zhi Wang, Jiakai He, Jifei Sun, Chunlei Guo, Zhongming Du, Limei Chen, Yi Luo, Deqiang Gao, Hong Yang et al. · 2022 · Frontiers in Neurology
The prevalence and economic burden of treatment-resistant depression in Thailand
Jirada Prasartpornsirichoke, N. Pityaratstian, Chayanit Poolvoralaks, Naphat Sirinimnualkul, Tanaporn Ormtavesub, Nimmavadee Hiranwattana, Sasitorn Phonsit, Teerayuth Rungnirundorn · 2023 · BMC Public Health
Nitrogen‐containing heterocyclic compounds: A ray of hope in depression?
Diksha Choudhary, Bhupinder Kumar, Rajwinder Kaur · 2024 · Chemical Biology & Drug Design
Intranasal esketamine for patients with major depressive disorder: A systematic review and meta-analysis
Soroush Oraee, Mohammadreza Alinejadfard, Hossein Golsorkh, Majid Sadeghian, Maryam Fanaei, Rosella Centis, Lia D’Ambrosio, Giovanni Sotgiu, Hossein Goudarzi, Giovanni Battista Migliori et al. · 2024 · Journal of Psychiatric Research
TMS Database Registry Consortium Research Project in Japan (TReC-J) for Future Personalized Psychiatry
Yoshihiro Noda, Junichiro Kizaki, Shun Takahashi, Masaru Mimura · 2022 · Journal of Personalized Medicine
Exome-wide association study of treatment-resistant depression suggests novel treatment targets
Shrey Shah, Teja Peddada, Christopher Song, Maame Mensah, Heejong Sung, Mani Yavi, Peixiong Yuan, Carlos A. Zarate, Brian J. Mickey, Margit Burmeister et al. · 2023 · Scientific Reports
Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials
G. Salvetti, Daniele Saccenti, Andrea Stefano Moro, Jacopo Lamanna, Mattia Ferro · 2024 · Brain Sciences
Systematic review of clinical effectiveness of interventions for treatment resistant late-life depression
Beatriz Pozuelo Moyano, Denise Gomez Bautista, Karla Jocelyn Porras Ibarra, Christoph Mueller, Armin von Gunten, Pierre Vandel, Setareh Ranjbar, Robert J. Howard, Allan Hunter Young, Robert J. Stewart et al. · 2025 · Ageing Research Reviews
Craving and addictive potential of esketamine as side effects?
Laura Orsolini, Virginio Salvi, Umberto Volpe · 2022 · Expert Opinion on Drug Safety
<p>The Long and Winding Road of Vagus Nerve Stimulation: Challenges in Developing an Intervention for Difficult-to-Treat Mood Disorders</p>
Sackeim, Harold A, Dibué, Maxine, Bunker, Mark T, Rush, A John · 2020 · Neuropsychiatric Disease and Treatment
The augmentative efficacy of second-generation anti-psychotics (SGA) to anti-depressants in treating treatment-resistant depression: a network meta-regression analysis
Bai, Binru, Li, Yuwei, Chen, Xi, Huang, Jinsong, Chen, Qiaoling, Du, Xinyuan, Huang, Chengfang, Yang, Yi · 2025 · BMC Psychiatry
Health-care utilisation and associated economic burden in major depressive disorder and treatment-resistant depression in a longitudinal population-based cohort study of 110.000 patients
Sofia Pappa, Moulesh Shah, Sophie Young, Tazneem Anwar, Timothy Ming · 2024 · Journal of Psychiatric Research
The Impact of Theta-Burst Stimulation on Cortical GABA and Glutamate in Treatment-Resistant Depression: A Surface-Based MRSI Analysis Approach
Benjamin Spurny‐Dworak, Godber Mathis Godbersen, Murray Bruce Reed, Jakob Unterholzner, Thomas Vanicek, P. Baldinger, Andreas Hahn, Georg S. Kranz, Wolfgang Bogner, Rupert R. Lanzenberger et al. · 2022 · Frontiers in Molecular Neuroscience
Early effects predict trajectories of response to esketamine in treatment-resistant depression
Isaure Estrade, Anne‐Cécile Petit, Vincent Sylvestre, Michel Danon, Sylvain Leroy, Rebecca Perrain, Fabien Vinckier, Lila Mékaoui, Raphaël Gaillard B, Emmanuelle Advenier-Iakovlev et al. · 2023 · Journal of Affective Disorders
Auditory entrainment coordinates cortical-BNST-NAc triple time locking to alleviate the depressive disorder
Xin Lv, Yuhan Wang, Yingying Zhang, Shuo Ma, Jie Liu, Kuanghao Ye, Yunhao Wu, Valerie Voon, Bomin Sun · 2024 · Cell Reports
Interventional approaches to treatment resistant depression (DTR) in children and adolescents: A systematic review and meta-analysis
Ethan Faries, Landon A. Mabe, Ronald Lee Franzen, Syed Murtaza, Komal Nathani, Burhan Ahmed, Larry J. Prokop, Khaled Mohammed, Ahmed T. Ahmed · 2024 · Journal of Affective Disorders
Healthcare resource utilization in patients with treatment-resistant depression—A Danish national registry study
Jensen, Kristoffer Jarlov, Gronemann, Frederikke Hørdam, Ankarfeldt, Mikkel Zöllner, Jimenez-Solem, Espen, Alulis, Sarah, Riise, Jesper, Bødker, Nikolaj, Osler, Merete, Petersen, Janne · 2022 · PLOS ONE
Recent advances in biomimetic nanodelivery systems for the treatment of depression
Ping Jiang, Jian Li · 2025 · Materials Today Bio
The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report
Matteo Marcatili, Cristian Pellicioli, Laura Maggioni, Federico Luigi Motta, Redaelli Chiara, Ghelfi Lorenzo, Krivosova Michaela, Matteo Sibilla, Roberto Nava, Fabrizia Colmegna et al. · 2021 · Annals of General Psychiatry
The Convergence Model of Brain Reward Circuitry: Implications for Relief of Treatment-Resistant Depression by Deep-Brain Stimulation of the Medial Forebrain Bundle
Vasilios Pallikaras, Peter Shizgal · 2022 · Frontiers in Behavioral Neuroscience
Inflammation‐stratified augmentation of vortioxetine with celecoxib: Results from a double‐blind, randomized, placebo‐controlled trial in major depressive disorder
Erhan Kavakbasi, Emma Sampson, Natalie T. Mills, Hikaru Hori, Kathrin Schwarte, Christa Hohoff, Klaus Oliver Schubert, Scott Richard Clark, Célia Fourrier, Bernhard Theodor Baune · 2023 · Journal of Neurochemistry
Treatment-resistant depression: role of genetic factors in the perspective of clinical stratification and treatment personalisation
Chiara Fabbri · 2025 · Molecular Psychiatry
Lost in translation. The quest for definitions of treatment-resistant depression with a focus on inflammation-related gene expression
Luca Sforzini · 2021 · Brain Behavior & Immunity - Health
Clinical and Biological Factors Are Associated with Treatment-Resistant Depression
Massimiliano Buoli, Enrico Capuzzi, Alice Caldiroli, Alessandro Ceresa, Cecilia Maria Esposito, Cristina Posio, Anna Maria Auxilia, Martina Capellazzi, Ilaria Tagliabue, Teresa Surace et al. · 2022 · Behavioral Sciences
Longitudinal alterations in mRNA expression of the BDNF neurotrophin signaling cascade in blood correlate with changes in depression scores in patients undergoing electroconvulsive therapy
Geert Schurgers, Sharon Walter, Ehsan Pishva, Sinan Gülöksüz, Odette Peerbooms, Laura Rodriguez Incio, Baer M.G. Arts, Günter Kenis, Bart P. F. Rutten · 2022 · European Neuropsychopharmacology
Rapid‐acting antidepressants targeting modulation of the glutamatergic system: clinical and preclinical evidence and mechanisms
Shikai Wang, Sufang Tang, Jintao Huang, Huanxin Chen · 2022 · General Psychiatry
Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study
Fernanda Palhano-Fontes, Patrícia Cavalcanti-Ribeiro, Kaike Thiê da Costa Gonçalves, Victor Rocha Nóbrega de Almeida, David Cavalcante Barbosa, Marcos André de Araújo Ferreira, Raynara Bolcont, Lara Carvalho Araújo Melo De Souza, Nestor Caetano dos Santos, Eduardo Igor Torquato Cardoso Lopes et al. · 2024 · Journal of Affective Disorders
The HPA axis and kynurenine pathway: exploring the role of stress and neuroinflammation in treatment-resistant depression
Madhura M Bose, Anusha Govindula, Madhavan Nampoothiri, Devinder S Arora, Jayesh Mudgal · 2025 · Pharmacological Reports
Change in patient‐centered outcomes of psychological well‐being, sleep, and suicidality following treatment with intravenous ketamine for late‐life treatment‐resistant depression
Benjamin Vanderschelden, Marie Anne Gebara, Hanadi Ajam Oughli, Meryl A. Butters, Patrick J. Brown, Nuri B. Farber, Alastair J. Flint, Jordan F. Karp, Helen Lavretsky, Benoit H. Mulsant et al. · 2023 · International Journal of Geriatric Psychiatry
Reduction in Cognitive Symptoms Following Intranasal Esketamine Administration in Patients With Chronic Treatment-resistant Depression: A 12-Week Case Series
Maria Pepe, Giovanni Bartolucci, Ilaria Marcelli, Alessio Simonetti, Giovanni Camardese, Marco Di Nicola, Gabriele Sani · 2023 · Journal of Psychiatric Practice
Association of Neurofilament Light Chain With the Antidepressant Effects of Low-Dose Ketamine Infusion Among Patients With Treatment-Resistant Depression
Wei‐Chen Lin, Tung‐Ping Su, Cheng‐Ta Li, Hui-Ju Wu, Ya‐Mei Bai, Yu‐Li Liu, Pei‐Chi Tu, Mu‐Hong Chen · 2023 · The International Journal of Neuropsychopharmacology
Difficult-To-Treat Depression. Scoping Review.
Walter Paganin, Sabrina Giovanna Signorini, Antonio Sciarretta · 2023 · PubMed Central
Neural correlates of treatment response to ketamine for treatment-resistant depression: A systematic review of MRI-based studies
Je‐Yeon Yun, Yong‐Ku Kim · 2024 · Psychiatry Research
Comparison on the clinical features in patients with or without treatment-resistant depression: A National Survey on Symptomatology of Depression report
Ying‐Ying Huang, Ping Sun, Zhiguo Wu, Xiaoyun Guo, Xiaohui Wu, Jun Chen, Lu Yang, Xiao Wu, Yiru Fang · 2022 · Psychiatry Research
Economic evaluation of interventions for treatment-resistant depression: A systematic review
Laura A. Hannah, Cathy M. Walsh, Louise Jopling, Jesús Pérez, Rudolf N. Cardinal, Rory A. Cameron · 2023 · Frontiers in Psychiatry
Neurological mechanism-based analysis of the role and characteristics of physical activity in the improvement of depressive symptoms
Wang, Nan, Zhu, Shanshan, Chen, Shuyang, Zou, Ju, Zeng, Peng, Tan, Sijie · 2025 · Reviews in the Neurosciences
Nitrous Oxide: an emerging novel treatment for treatment-resistant depression
Darin F. Quach, Victoria de León-Martínez, Charles R. Conway · 2021 · Journal of the Neurological Sciences
Treatment-Resistant Depression in Portugal: Perspective From Psychiatry Experts
João Miguel Bessa, Serafim Carvalho, Inês B. Cunha, Milene Fernandes, Ana Matos-Pires, Rui Neves, Albino Jorge Oliveira-Maia, Susana Gomes Santos, Vítor Santos · 2022 · Frontiers in Psychiatry
Baseline characteristics of a European patient population with difficult-to-treat depression (RESTORE-LIFE) treated with adjunctive vagus nerve stimulation
Koen Demyttenaere, Tiago Costa, Erhan Kavakbasi, Mei Jiang, An Scheltens, Maxine Dibué, Beth Hall, Pablo Andrade, Hamish McAllister-Williams, Bernhard Theodor Baune et al. · 2023 · Journal of Affective Disorders
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression
R. Yan, Tyler Marshall, A. Khullar, T. Nagle, J. Knowles, M. Malkin, Brittany Chubbs, J. Swainson · 2024 · Therapeutic Advances in Psychopharmacology
The role of KCNQ channel activators in management of major depressive disorder
Shakila Meshkat, Angela T.H. Kwan, Gia Han Le, Sabrina Wong, Taeho Greg Rhee, Roger Ho, Kayla M. Teopiz, Bing Cao, Roger S. McIntyre · 2024 · Journal of Affective Disorders
A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope?
Simone Pardossi, Andrea M. Fagiolini, Simona Scheggi, Alessandro Cuomo · 2024 · Children
Enzymatic biomarkers of oxidative stress in patients with depressive disorders. A systematic review
Francisco Javier Lievanos-Ruiz, Bertha Fenton-Navarro · 2024 · Clinical Biochemistry
Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms
Matteo Marcatili, Carlo Sala, Antonios Dakanalis, Fabrizia Colmegna, Armando D’Agostino, Orsola Gambini, Bernardo Maria Dell’Osso, Beatrice Benatti, Luciano Conti, Massimo Clerici · 2020 · Therapeutic Advances in Psychopharmacology
Dopamine DRD2 and DRD3 Polymorphisms Involvement in Nicotine Dependence in Patients with Treatment-Resistant Mental Disorders
Antonio DEL CASALE, Marco Paolini, Giovanna Gentile, Marina Borro, Clarissa Zocchi, Federica Fiaschè, Alessio Padovano, Teodolinda Zoppi, Martina Nicole Modesti, Ottavia De Luca et al. · 2022 · Journal of Personalized Medicine
Efficacy and tolerability of minocycline in depressive patients with or without treatment-resistant: a meta-analysis of randomized controlled trials
Youjia Qiu, Aojie Duan, Ziqian Yin, Minjia Xie, Zhouqing Chen, Xiaoou Sun, Zhong Wang, Xuwei Zhang · 2023 · Frontiers in Psychiatry
Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder
Marco Paolini, Lidia Fortaner-Uyà, Cristina Lorenzi, Sara Spadini, Melania Maccario, Raffaella Zanardi, Cristina Colombo, Sara Poletti, Francesco Benedetti · 2023 · Genes
Care pathways, prescribing practices and treatment outcomes in major depressive disorder and treatment-resistant depression: retrospective, population-based cohort study
Sofia Pappa, Moulesh Shah, Sophie Young, Tazneem Anwar, Timothy Ming · 2024 · BJPsych Open
Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures
Hanbo Yao, Xiaodong Wang, Jiaxin Chi, Haorong Chen, Yilin Liu, Yang Jiayi, Jiaqi Yu, Yongdui Ruan, Xufu Xiang, Jiang Pi et al. · 2024 · Molecules
How different definition criteria may predict clinical outcome in treatment resistant depression: Results from a prospective real-world study
Raffaella Zanardi, Matteo Carminati, Francesco Attanasio, Valentina Fazio, Melania Maccario, Cristina Colombo · 2024 · Psychiatry Research
Major challenges in youth psychopathology: treatment-resistant depression. A narrative review
Giulia Menculini, Gianmarco Cinesi, Francesca Scopetta, Matteo Cardelli, Guido Caramanico, Pierfrancesco Maria Balducci, Filippo De Giorgi, Patrizia Moretti, Alfonso Antonio Vincenzo Tortorella · 2024 · Frontiers in Psychiatry
Inflammatory cytokines, cortisol, and anhedonia in patients with treatment-resistant depression after consecutive infusions of low-dose esketamine
Yue Wang, Qiongyao Yang, Chuanchuan Chen, Yitan Yao, Xiaoping Yuan, Kai Zhang · 2024 · European Archives of Psychiatry and Clinical Neuroscience
Cost‐Effectiveness of rTMS as a Next Step in Antidepressant Non‐Responders: A Randomized Comparison With Current Antidepressant Treatment Approaches
Iris Dalhuisen, Kim Anh Bui, Anne Kleijburg, Iris van Oostrom, Jan Spijker, Eric R. van Exel, Hans C. van Mierlo, Dieuwertje de Waardt, Martijn Arns, Indira Tendolkar et al. · 2024 · Acta Psychiatrica Scandinavica
Therapeutic Shifts and Scientific Influence in Treatment-Resistant Depression Research: A Data-Driven Perspective
Yunsheng Liu, Zengwei Kou · 2025 · Biological Psychiatry Global Open Science
Optimal parameter determination of repetitive transcranial magnetic stimulation for treating treatment-resistant depression: A network meta-analysis of randomized controlled trials
Jinbiao Li, Liqian Cui, Hao Li · 2022 · Frontiers in Psychiatry
Genetics of antidepressant response and treatment-resistant depression
An-Nie Chung, Tzu‐Ting Chen, Kuang Lin · 2023 · Progress in brain research
Targeting HINT1 to improve synaptic plasticity: toward loganin as a new antidepressant strategy
Cong‐Yuan Xia, Guo‐Yan Zuo, Manni Wang, Yuming Wang, Yuxuan Guo, Yan Han, Honglin Xiang, Yung‐Chi Cheng, Jie‐Kun Xu, Jun He et al. · 2025 · Molecular Psychiatry
Lower antidepressant response to fluoxetine is associated with anxiety-like behavior, hippocampal oxidative imbalance, and increase on peripheral IL-17 and IFN-γ levels
Brenda Moreira dos Santos, Gabriele Cheiran Pereira, Elisa Piton, Maria Fernanda Pessano Fialho, Gabriela Becker, Marieli da Silva Carlotto, Luís Fernando Muniz Camargo, Luís Guilherme Ramanzini, Sara Marchesan Oliveira, Gabriela Trevisan et al. · 2022 · Behavioural Brain Research
National trends and correlates of treatment resistance in major depressive episode and associated suicidal ideation and behaviors among adults in the United States
Taeho Greg Rhee, Tanner J. Bommersbach, Robert Alan Rosenheck, Andrew Alan Nierenberg, Roger S. McIntyre · 2024 · Journal of Affective Disorders
The mediating role of family functioning between childhood trauma and depression severity in major depressive disorder and bipolar disorder
Yishan Du, Jiayu Liu, Ran Lin, Mohammad Ridwan Chattun, Wenyue Gong, Lingling Hua, Hao Tang, Yinglin Han, Qing Lü, Zhijian Yao · 2024 · Journal of Affective Disorders
Research progress on the mechanism of antidepressant effect of salidroside
Weiyi Ao, Wenbo Gao, Tian Li · 2025 · International Immunopharmacology
Editorial: The glutamate hypothesis of mood disorders: Neuroplasticity processes, clinical features, treatment perspectives
Riccardo Guglielmo, Rocco de Filippis, Sami Ouanes, Gregor Hasler · 2022 · Frontiers in Psychiatry
Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis
Fang, Qiwen, Chan, Vivien Kin Yi, Chan, Sandra Sau Man, Jiao, Yuanshi, Wang, Jiaqi, Li, Xue · 2024 · Psychiatry Research
Different characteristics of striatal resting-state functional conectivity in treatment-resistant and non-treatment-resistant depression
Jifei Sun, Linjie Xu, Yue Ma, Chunlei Guo, Zhongming Du, Shanshan Gao, Yi Luo, Qingyan Chen, Hong Yang, Xue Yu et al. · 2022 · Psychiatry Research Neuroimaging
Dexmedetomidine in the Treatment of Depression: An Up-to-date Narrative Review
Tamadhir Al-Mahrouqi, Mohammed Al‐Alawi, Rafael C. R. Freire · 2023 · Clinical Practice and Epidemiology in Mental Health
A Multi-Center, Open-Label, Single-Arm Study to Investigate the Early Effectiveness of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Using a Mobile Self-Monitoring Application
Junhyung Kim, Seung‐Hoon Lee, Cheolmin Shin, Kyu‐Man Han, Sung Joon Cho, Narei Hong, Changsu Han · 2024 · Pharmaceuticals
Safety and effectiveness of vortioxetine for major depressive disorder: Real-world evidence from a population-based study in South Korea
Seok Woo Moon, Jee Wook Kim, Do Hoon Kim, Kyu Young Lee, Elin Heldbo Reines, Minah Lee, Yoo Jin Park · 2023 · Frontiers in Psychiatry
Single Subcutaneous Ketamine Dose Followed by Oral Ketamine for Depression Symptoms in Hospice Patients: A Case Series
Natalie M. Latuga, Debra L. Luczkiewicz, Pei C. Grant, Kathryn Levy, Eric Hansen, Christopher W. Kerr · 2021 · Journal of Pain & Palliative Care Pharmacotherapy
Severe and complex youth depression: Clinical and historical features of young people attending a tertiary mood disorders clinic
Simon Rice, Ben McKechnie, Sue Cotton, Abi Brooker, Vita Pilkington, Belinsha Youzchalveen, Lianne Schmaal, Christopher G. Davey · 2021 · Early Intervention in Psychiatry
First Acute-Course Electroconvulsive Therapy for Moderate-to-Severe Depression Benefits Patients With or Without Accompanying Baseline Cognitive Impairment
Marc L. Copersino, Marina P. Long, Paula Bolton, Kerry James Ressler, Stephen J. Seiner, Agustin G. Yip · 2021 · Journal of Ect
Adjunctive vagus nerve stimulation for treatment-resistant depression: a preliminary study
Xun Zhang, Yan‐Mei Guo, Yuping Ning, Liping Cao, Ying-Hua Rao, Jiaqi Sun, Ming-Jun Qing, Wei Zheng · 2022 · International Journal of Psychiatry in Clinical Practice
Impaired socio-affective, but intact socio-cognitive skills in patients with treatment-resistant, recurrent depression
Hannah M. Kilian, Bastian Schiller, Thomas Eduard Schläpfer, Markus Heinrichs · 2022 · Journal of Psychiatric Research
A comparative study of amplitude of low-frequence fluctuation of resting-state fMRI between the younger and older treatment-resistant depression in adults
Jifei Sun, Chunlei Guo, Yue Ma, Zhongming Du, Zhi Wang, Yi Luo, Limei Chen, Deqiang Gao, Xiaojiao Li, Ke Xu et al. · 2022 · Frontiers in Neuroscience
A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant Depression
Phern Chern Tor, Nurmiati Amir, Johnson Fam, Roger Ho, Pichai Ittasakul, Margarita Maria Maramis, Benita Ponio, Dharmawan Ardi Purnama, Wanida Rattanasumawong, Elizabeth Rondain et al. · 2022 · Neuropsychiatric Disease and Treatment
Cortical inhibition function is associated with baseline suicidal symptoms and post-ketamine suicidal symptom reduction among patients with treatment-resistant depression and strong suicidal ideation
Mu‐Hong Chen, Tung‐Ping Su, Li‐Fen Chen, Cheng‐Ta Li, Hui-Ju Wu, Wei‐Chen Lin, Shih‐Jen Tsai, Ya‐Mei Bai, Wei‐Chung Mao, Pei‐Chi Tu et al. · 2023 · Journal of Psychiatric Research
Rethinking the role of trazodone in the different depressive dimensions
Isabella Berardelli, Andrea Amerio, Francesco Bartoli, Alessandro Cuomo, Giacomo Deste, Laura Orsolini, Gaia Sampogna, Maurizio Pompili · 2024 · Expert Review of Neurotherapeutics
Altered brain function in treatment-resistant depression patients: A resting-state functional magnetic resonance imaging study
Weijian Han, Xiaohui Wu, Ligang Wang, Chunhui Qu, Liqiang Dou, Yiru Fang, Ping Sun · 2024 · Neuroscience Letters
Genome-wide association meta-analysis and rare copy number variant analysis of treatment-resistant depression
Ying Xiong, Kristi Krebs, Bradley S. Jermy, Robert Karlsson, Joëlle A. Pasman, Thuy-Dung Nguyen, Tong Gong, Kaarina Kowalec, Christian Rück, Robert Sigström et al. · 2025 · Molecular Psychiatry
Research Progress on the Biological Function and Homeostatic Disruption of Microglia in the Pathogenesis of Major Depressive Disorder
Shuqi Kong, Zhuoyue Huang, Yiru Fang · 2026 · Neuroscience Bulletin
Esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A real-world longitudinal study of suicidal ideation and self-harm
F. Raffone, Filippo Mazzoni, Arianna De Ciechi, Nicolaja Girone, Monica Macellaro, Giovanni Martinotti, Bernardo Maria Dell’Osso, Miriam Olivola, Vassilis Martiadis · 2026 · Asian Journal of Psychiatry
Dietary Patterns of Treatment–Resistant Depression Patients
Agnieszka Mechlińska, Adam Włodarczyk, Marta Gruchała‐Niedoszytko, Sylwia Małgorzewicz, Wiesław Jerzy Cubała · 2022 · Nutrients
Magnetic Waves vs. Electric Shocks: A Non-Inferiority Study of Magnetic Seizure Therapy and Electroconvulsive Therapy in Treatment-Resistant Depression
Helena Bellini, Eric Cretaz, Adriana Munhoz Carneiro, Pedro Henrique Rodrigues da Silva, Leonardo Afonso dos Santos, José Gallucci Neto, André R. Brunoni · 2023 · Biomedicines
Latin American consensus recommendations for the management and treatment of patients with treatment-resistant depression (TRD)
Ricardo Marcelo Corral, Enrique Bojórquez Giraldo, Marcelo Cetkovich, Rodrigo Córdoba, Julio Chestaro, Clarissa Severino Gama, Gerardo García Bonetto, Carlos López‐Jaramillo, Ricardo Alberto Moreno, Bernardo Ng et al. · 2023 · Revista de Psiquiatría y Salud Mental
Cognitive Profiles in Treatment-Resistant Late-Life Depression and their Impact on Treatment Outcomes.
Katharina Göke, Shawn M. McClintock, Linda Mah, T. Rajji, Hyewon H. Lee, S. Nestor, J. Downar, Y. Noda, Z. Daskalakis, B. Mulsant et al. · 2024 · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Heart Rate Variability as a Potential Predictor of Response to Intranasal Esketamine in Patients with Treatment-Resistant Depression: A Preliminary Report
Lorenzo Moccia, Giovanni Bartolucci, Maria Pepe, Ilaria Marcelli, Flavia Grisoni, Andrea Brugnami, Romina Caso, Francesca Bardi, Claudia Calderoni, Alessandro Michele Giannico et al. · 2024 · Journal of Clinical Medicine
The Role of the Patient-Centered Medical Home in Treating Depression
Olivia E. Bogucki, Mark D. Williams, Leif I. Solberg, Rebecca C. Rossom, Craig N. Sawchuk · 2020 · Current Psychiatry Reports
One-year incidence rate of Treatment Resistant Depression (TRD) and treatment characteristics in China
Huaning Wang, Tina Wu, Sijia Dong, Muzhen Guan, Ao Liu, Kun Jiang, Rui Chi, Hong Xia Qiu, Wentian Dong, Tianmei Si · 2022 · Journal of Affective Disorders
Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study
Antonio DEL CASALE, Leda Marina Pomes, Luca Bonanni, Federica Fiaschè, Clarissa Zocchi, Alessio Padovano, Ottavia De Luca, Gloria Angeletti, Roberto Brugnoli, Paolo Girardi et al. · 2022 · Journal of Personalized Medicine
The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review
Carolina Sepulveda Ramos, Matthew Thornburg, Kelly Long, Kiran Sharma, Julia Roth, Diana Lacatusu, Reece Whitaker, Daniel Pacciulli, Sulma Moredo Loo, Mohammad Manzoor et al. · 2022 · Cureus
Structural brain plasticity and inflammation are independently related to changes in depressive symptoms six months after an index ECT course
John O. Brooks, Jennifer L. Kruse, Antoni Kubicki, Gerhard Hellemann, Randall T. Espinoza, Michael R. Irwin, Katherine L. Narr · 2023 · Psychological Medicine
A single subanaesthetic dose of the rapid-acting antidepressant S-ketamine raises presynaptic SV2A density in limbic regions of the Wistar Kyoto rat model of depression
Bærentzen, Simone Larsen, Waszkiewicz, Anna Lee, Thomsen, Majken, Knudsen, Celine, Elfving, Betina, Landau, Anne M. · 2024 · Neuroscience Applied
Acute treatment of bilateral rTMS combined with antidepressants on the plasma fatty acids for major depressive episodes
Rui Li, Rui Fu, Wenmao Yang, Zhi-quan Cui, Xue‐jun Liang, Jia-bin Yang, Ling Liu, Qingrong Tan, Zhengwu Peng · 2024 · Brain Research